Evidence map›Paper›PMID 33118928›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2021

Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study.

Rébecca Robillard, Mysa Saad, Laura B Ray, Brad BuJáki, Alan Douglass, Elliott K Lee, Louis Soucy, Naomi Spitale, Joseph De Koninck, Tetyana Kendzerska

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05470465 (Clinical Study to Investigate the Effect of Administration of Selective Serotonin Reuptake Inhibitors), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05470465 phase1completednot on this mapstarted 2022, after this paper: background citation

Clinical Study to Investigate the Effect of Administration of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation

TypeinterventionalSponsorFood and Drug Administration (FDA)Ran2022 to 2023Enrolled27ConditionsHypercapnia, Ventilatory DepressionArmsPlacebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and Oxycodone
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Sex and age differences in sleep disorders: insights from a diverse cohort referred to a sleep center.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Revisiting the Role of Serotonin in Sleep-Disordered Breathing.International journal of molecular sciences · 2024
    Review
  11. Sleep apnea pathophysiology.Sleep & breathing = Schlaf & Atmung · 2023
    Review
  12. [Current Status of and Progress in Research on Obstructive Sleep Apnea and Comorbid Depressive Disorders].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Rébecca RobillardSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Mysa SaadSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Laura B RaySleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Brad BuJákiSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Alan DouglassSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Elliott K LeeSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Louis SoucySleep Disorders Clinic, Royal Ottawa Mental Health Centre, Ottawa, Canada.
Naomi SpitaleSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Joseph De KoninckSleep Research Unit, The Royal's Institute of Mental Health Research, Ottawa, Canada.
Tetyana KendzerskaFaculty of Medicine, University of Ottawa, Ottawa, Canada.
Royal Ottawa Mental Health Centre · CAUniversity of Ottawa · CAOttawa Hospital Research Institute

Funding

CIHR
6 · The paper itself

Abstract

STUDY

objectivesThe effects of serotonergic agents on respiration neuromodulation may vary according to differences in the serotonin system, such as those linked to depression. This study investigated how sleep-related respiratory disturbances relate to depression and the use of medications commonly prescribed for depression.

methodsRetrospective polysomnography was collated for all 363 individuals who met selection criteria out of 2,528 consecutive individuals referred to a specialized sleep clinic (Ottawa, Canada) between 2006 and 2016. The apnea-hypopnea index (AHI), oxygen saturation nadir, and oxygen desaturation index during REM and NREM sleep were analyzed using mixed analyses of covariance comparing 3 main groups: (1) medicated individuals with depressive disorders (antidepressant group; subdivided into the selective serotonin reuptake inhibitor and norepinephrine-dopamine reuptake inhibitor subgroups), (2) non-medicated individuals with depressive disorders (non-medicated group), and (3) mentally healthy control patients (control group).

resultsIndividuals with depressive disorders (on antidepressants or not) had significantly higher AHIs compared to control patients (both P ≤ .007). The antidepressant group had a lower NREM sleep oxygen saturation nadir and a higher NREM sleep oxygen desaturation index than the control and non-medicated groups (all P ≤ .009). Within individuals with depressive disorders, independent of depression severity, the selective serotonin reuptake inhibitor group had a lower oxygen saturation nadir and a higher oxygen desaturation index during NREM sleep than the norepinephrine-dopamine reuptake inhibitor (both P ≤ .045) and non-medicated groups (both P < .001) and a higher NREM sleep AHI than the non-medicated group (P = .014).

conclusionsThese findings suggest that the use of selective serotonin reuptake inhibitors may be associated with impaired breathing and worse nocturnal oxygen saturation in individuals with depressive disorders and sleep complaints, but this needs to be confirmed by prospective studies.

Indexed as

Depressive DisorderSleep Apnea, ObstructiveCanadaHumansProspective StudiesRespirationRetrospective StudiesSelective Serotonin Reuptake InhibitorsSleepSelective Serotonin Reuptake InhibitorsantidepressantsdepressionOSAselective serotonin reuptake inhibitorsleep-related breathing disturbances

Identifiers

PMID33118928
PMCPMC7927326
OpenAlexW3096784486

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.